Accrued Expenses

9 Months Ended

Sep. 30, 2020

Payables and Accruals [Abstract]

Accrued Expenses

Note 5. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

		September 30,		December 31,
		2020		2019
Clinical trial expenses	$	2,538,702	$	3,020,030
Other		108,522		137,356
Total	$	2,647,224	$	3,157,386